Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation and analgesia with dexmedetomidine, fentanyl, and intrathecal neostigmine in femoral fracture surgery
IRCT20191104045328N33Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, fentanyl and neostigmine in femoral fracture, sponsored by Arak University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
dexmedetomidinefentanylneostigmine
03
Conditions
femoral fracture
Beyond the preview
Go deeper on IRCT20191104045328N33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N33.